Molecular Mechanisms in Schizophrenia Pathophysiology

Schizophrenia arises from an intricate interplay of genetic predisposition and molecular disturbances that converge on intracellular signalling networks, synaptic function and neurodevelopmental trajectories. Central to its pathophysiology are dysregulations of dopamine and glutamate transmission, entwined with aberrant GABAergic inhibition. At the molecular level, imbalances in kinase and phosphatase activities perturb phosphorylation cascades governing receptor trafficking, cytoskeletal dynamics and gene expression. The PI3K–Akt–mTOR axis emerges as a pivotal nexus: altered Akt phosphorylation and downstream mTOR complex dysfunction lead to impaired protein synthesis, disrupted synaptic plasticity and deficient neuronal growth. Concurrently, anomalies in signal transduction kinomes reveal that subtle shifts in enzyme activity, rather than gross protein abundance, underpin widespread neurochemical deficits. These perturbations manifest as impaired cortical–subcortical connectivity, hypofrontality, and the characteristic cognitive and negative symptoms of schizophrenia. Recent advances highlight how epistatic interactions between risk genes further modulate these pathways, while peripheral biomarkers of signalling proteins hint at translational opportunities. Understanding these molecular underpinnings is vital for the development of targeted therapeutics that restore signalling homeostasis and ameliorate core manifestations of the disorder.

Research from Nature Portfolio

Studies of Akt1 deficiency have demonstrated its non-redundant role in GABAergic interneuron differentiation and hippocampus-dependent cognition. In female Akt1-knockout models, reduced parvalbumin-positive interneuron abundance and diminished GABAA receptor expression correlated with impaired spatial memory and altered hippocampal oscillations, implicating Akt1 as a key regulator of inhibitory microcircuits. Another investigation quantified the balance of DARPP-32 and calcineurin proteins in postmortem prefrontal and accumbal regions. In schizophrenia subjects, diminished DARPP-32 alongside elevated calcineurin in the prefrontal cortex disrupted dopaminergic signal integration, indicating a shift towards phosphatase-dominant states that may underlie negative and cognitive symptoms.

Molecular Mechanisms in Schizophrenia Pathophysiology publication trend

The graph below shows the total number of articles in molecular mechanisms in schizophrenia pathophysiology across all publications each year (not limited to Nature Index journals).

Technical terms

Akt1: A serine/threonine kinase in the PI3K pathway that regulates cell growth, survival and synaptic function.

mTORC1: Mechanistic target of rapamycin complex 1, a key regulator of protein synthesis and cellular metabolism.

GABAergic interneurons: Inhibitory neurons that release gamma-aminobutyric acid to modulate cortical and hippocampal circuits.

Kinase: An enzyme that catalyses the transfer of a phosphate group to proteins, altering their activity.

Phosphorylation: The addition of a phosphate group to a molecule, often regulating protein function and signalling.

DARPP-32: Dopamine- and cAMP-regulated phosphoprotein of 32 kDa that integrates multiple neurotransmitter signals.

Calcineurin: A calcium-activated phosphatase that dephosphorylates target proteins, counterbalancing kinase activity.

References

1. Abnormalities of signal transduction networks in chronic schizophrenia. Schizophrenia (2017).
2. Akting up in the GABA hypothesis of schizophrenia: Akt1 deficiency modulates GABAergic functions and hippocampus-dependent functions. Scientific Reports (2016).
3. Differential protein expression of DARPP-32 versus Calcineurin in the prefrontal cortex and nucleus accumbens in schizophrenia and bipolar disorder. Scientific Reports (2019).
4. Ribosomal Protein S6 Hypofunction in Postmortem Human Brain Links mTORC1-Dependent Signaling and Schizophrenia. Frontiers in Pharmacology (2020).
5. The mammalian target of rapamycin (mTOR) kinase mediates haloperidol-induced cataleptic behavior. Translational Psychiatry (2020).
6. Investigation of gene effects and epistatic interactions between Akt1 and neuregulin 1 in the regulation of behavioral phenotypes and social functions in genetic mouse models of schizophrenia. Frontiers in Behavioral Neuroscience (2015).